Myriad Genetics Inc
XHAM:MYD
Myriad Genetics Inc
XHAM:MYD
Price:
3.256
EUR
0.65%
Market Closed
Market Cap:
€292.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Myriad Genetics Inc
XHAM:MYD
|
US |
|
Connect Biopharma Holdings Ltd
NASDAQ:CNTB
|
CN |
|
Gates Industrial Corporation PLC
F:1JL
|
US |
|
Experian PLC
LSE:EXPN
|
IE |
|
Lonza Group AG
F:LO3
|
CH |
|
Helen of Troy Ltd
NASDAQ:HELE
|
BM |
|
I
|
IDNTT SA
MIL:IDNTT
|
CH |
|
I
|
Ingredion Inc
XBER:CNP
|
US |
|
S
|
Saipem SpA
LSE:0RPI
|
IT |
|
N
|
Newmont Corporation
XHAM:NMM
|
US |
|
A
|
Archrock Inc
XBER:54E
|
US |
|
T
|
Target Corp
SGO:TGT
|
US |
|
E
|
Equity Residential
SWB:EQR
|
US |
|
Blink Charging Co
NASDAQ:BLNK
|
US |
|
U
|
Unilever PLC
SWB:UNVB
|
UK |
|
Deep Yellow Ltd
ASX:DYL
|
AU |
|
O
|
Opendoor Technologies Inc
F:25M
|
US |
Multiples-Based Value
The Multiples-Based Value for 
Myriad Genetics Inc (MYD) under the Base Case is hidden
EUR.
Compared with the current market price of 3.256 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
MYD Multiples-Based Value
LOCKED
